ArticleOncology letters2025

Analysis of camrelizumab in neoadjuvant chemotherapy for esophageal cancer: A retrospective cohort study.

Jianjun Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.